Evaluation of a clinical-grade, cryopreserved, ex vivo-expanded stem cell product from cryopreserved primary umbilical cord blood demonstrates multilineage hematopoietic engraftment in mouse xenografts.

Autor: Schaniel C; Division of Hematology/Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Mount Sinai Institute for Systems Biomedicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: christoph.schaniel@mssm.edu., Papa L; Division of Hematology/Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Meseck ML; Division of Hematology/Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Kintali M; Division of Hematology/Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Djedaini M; Division of Hematology/Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Zangui M; Division of Hematology/Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Iancu-Rubin C; Division of Hematology/Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Division of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Hoffman R; Division of Hematology/Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Publikováno v: Cytotherapy [Cytotherapy] 2021 Sep; Vol. 23 (9), pp. 841-851. Date of Electronic Publication: 2021 May 19.

Limited Mitochondrial Activity Coupled With Strong Expression of CD34, CD90 and EPCR Determines the Functional Fitness of ex vivo Expanded Human Hematopoietic Stem Cells.

Autor: Papa L; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Djedaini M; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Martin TC; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Zangui M; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Beaumont KG; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Sebra R; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Parsons R; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Schaniel C; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Mount Sinai Institute for Systems Biomedicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Hoffman R; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

Publikováno v: Frontiers in cell and developmental biology [Front Cell Dev Biol] 2020 Dec 15; Vol. 8, pp. 592348. Date of Electronic Publication: 2020 Dec 15 (Print Publication: 2020).

Morin Inhibits Cell Proliferation and Induces Caspase-mediated Apoptotic Cell Death in Glioma C6 Cell Line.

Autor: Zhu, Shan¹ (AUTHOR), Yuan, Huisheng² (AUTHOR), Alahmadi, Tahani Awad³ (AUTHOR), Almoallim, Hesham S.⁴ (AUTHOR), Wang, ChangLi³ (AUTHOR) wangchangli2021@outlook.com

Publikováno v: Pharmacognosy Magazine. Jun2024, Vol. 20 Issue 2, p494-504. 11p.

Current evidence and future perspectives for curcumin and its analogues as promising adjuncts to oxaliplatin: state-of-the-art.

Autor: Zangui M; School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran., Atkin SL; Weill Cornell Medicine Qatar, Doha, Qatar., Majeed M; Sabinsa Corporation, East Windsor, NJ, United States., Sahebkar A; Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: sahebkara@mums.ac.ir.

Publikováno v: Pharmacological research [Pharmacol Res] 2019 Mar; Vol. 141, pp. 343-356. Date of Electronic Publication: 2019 Jan 11.

Protective effects of naringin against oxaliplatin-induced testicular damage in rats: Involvement of oxidative stress, inflammation, endoplasmic reticulum stress, apoptosis, and histopathology.

Autor: Akaras, Nurhan¹ nurhanakaras@aksaray.edu.tr, Gür, Cihan², Caglayan, Cuneyt³, Kandemir, Fatih Mehmet⁴

Publikováno v: Iranian Journal of Basic Medical Sciences. Apr2024, Vol. 27 Issue 4, p466-474. 9p.